---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-25-000006"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:12:38.049237+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sotera Health expects FY2024 revenue ~$1.1B (+5% YoY), within prior guidance

## Summary
- Preliminary full-year 2024 revenue of approximately $1.1 billion.
- Revenue growth of nearly 5% versus 2023, >5% on a constant currency basis.
- Revenue range within guidance provided at Q3 2024 earnings release.
- Full FY2024 results and 2025 outlook to be reported on February 27, 2025.
- Chairman and CEO presented business update at J.P. Morgan Healthcare Conference.

## SEC filing metadata
- accession: 0001822479-25-000006
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000006/0001822479-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000006/shc-20250114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-25-000006
- JSON: https://secwatch.observer/filing/0001822479-25-000006.json
- Plain text: https://secwatch.observer/filing/0001822479-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.